black box warning for glp 1 agonists National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FAQ of the Month: Is

Additionally, some individuals may experience side effects, such as nausea or digestive issues, which often require adjusting the dosage under medical supervision

Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors

So what we do is we take a naturally occurring hormone, we take it out, synthesize it into pharmacologic amounts, give it back to individuals, so we're able to amplify these satiety signals that someone's not quite getting, so they feel full

Multi-society clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period

The effects of semaglutide on kidney oxygenation, albuminuria and eGFR will be assessed in people with type 1 diabetes as part of the REMODEL-T1D mechanistic trial (NCT05822609)